Evidence map›Paper›PMID 35005710›Full record

ArticleHarvard data science review2020

On the Convergence of Epidemiology, Biostatistics, and Data Science.

Neal D Goldstein, Michael T LeVasseur, Leslie A McClure

Abstract read
In one paragraph

Article in Harvard data science review, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. How to write statistical analysis section in medical research.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2022
    Article
  7. Article
  8. Article
  9. The intersection of big data and epidemiology for epidemiologic research: The impact of the COVID-19 pandemic.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2021
    Article
  10. Biostatistics to better detect fishy findings.The Lancet. Infectious diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Neal D GoldsteinNeal D. Goldstein is an assistant research professor, Michael T. LeVasseur is a visiting assistant teaching professor, and Leslie A. McClure is a professor and chair of the Department of Epidemiology and Biostatistics at the Drexel University Dornsife School of Public Health, Philadelphia, PA, USA.
Michael T LeVasseurNeal D. Goldstein is an assistant research professor, Michael T. LeVasseur is a visiting assistant teaching professor, and Leslie A. McClure is a professor and chair of the Department of Epidemiology and Biostatistics at the Drexel University Dornsife School of Public Health, Philadelphia, PA, USA.
Leslie A McClureNeal D. Goldstein is an assistant research professor, Michael T. LeVasseur is a visiting assistant teaching professor, and Leslie A. McClure is a professor and chair of the Department of Epidemiology and Biostatistics at the Drexel University Dornsife School of Public Health, Philadelphia, PA, USA.

Funding

Towards prevention of HIV among vulnerable and stigmatized populations using geospatial dataK01AI143356 · NIAID · DREXEL UNIVERSITY · PI GOLDSTEIN, NEAL D · 2019 to 2023
$607k
NIAID NIH HHS K01 AI143356
6 · The paper itself

Abstract

Epidemiology, biostatistics, and data science are broad disciplines that incorporate a variety of substantive areas. Common among them is a focus on quantitative approaches for solving intricate problems. When the substantive area is health and health care, the overlap is further cemented. Researchers in these disciplines are fluent in statistics, data management and analysis, and health and medicine, to name but a few competencies. Yet there are important and perhaps mutually exclusive attributes of these fields that warrant a tighter integration. For example, epidemiologists receive substantial training in the science of study design, measurement, and the art of causal inference. Biostatisticians are well versed in the theory and application of methodological techniques, as well as the design and conduct of public health research. Data scientists receive equivalently rigorous training in computational and visualization approaches for high-dimensional data. Compared to data scientists, epidemiologists and biostatisticians may have less expertise in computer science and informatics, while data scientists may benefit from a working knowledge of study design and causal inference. Collaboration and cross-training offer the opportunity to share and learn of the constructs, frameworks, theories, and methods of these fields with the goal of offering fresh and innovate perspectives for tackling challenging problems in health and health care. In this article, we first describe the evolution of these fields focusing on their convergence in the era of electronic health data, notably electronic medical records (EMRs). Next we present how a collaborative team may design, analyze, and implement an EMR-based study. Finally, we review the curricula at leading epidemiology, biostatistics, and data science training programs, identifying gaps and offering suggestions for the fields moving forward.

Indexed as

biostatisticscausal inferencedata scienceelectronic medical recordsepidemiologystudy designtraining and education

Identifiers

PMID35005710
PMCPMC8734556

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.